Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety.
This study has been completed.
Information provided by:
First received: November 4, 2008
Last updated: March 5, 2009
Last verified: March 2009
To prove the safety of the gynaecological formulation in normal conditions of use.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||Safety Dermatological Evaluation: Genital Mucous Irritation - Product Tested: Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid).|
Resource links provided by NLM:
Further study details as provided by Sanofi:
Primary Outcome Measures:
- The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction. [ Time Frame: From the treatment start to the end of the study ] [ Designated as safety issue: No ]
|Study Start Date:||August 2008|
|Primary Completion Date:||September 2008 (Final data collection date for primary outcome measure)|
Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid)
|Drug: Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid)|
Contacts and Locations